Figure 2From: Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancerRepresentative photomicrographs of TGase 2 immunostaining in arrayed NSCLC tissues. The left and right columns represent examples of adenocarcinoma and squamous cell carcinoma showing (A) negative, (B) weak, (C) moderate and (D) strong immunoreactivity, respectively. Original magnification: ×400.Back to article page